Prolapse Repair
Pelvic organ prolapse (POP) repair encompasses native-tissue, mesh-augmented, and obliterative procedures targeting the anterior, posterior, and apical compartments. Surgical planning must account for compartment-specific anatomy (DeLancey Levels I–III), patient goals including uterine preservation and sexual activity, prior surgery, and mesh history.
See POP Overview for pathophysiology, risk stratification, and trial data (OPTIMAL, PEOPLE).
General Principles
- Principles of Prolapse RepairACOG PB 214 framework, SUPeR trial 2024 (sacrocolpopexy 28% / TVM 29% / native tissue 43% composite failure at 36 months), the 2026 Cochrane anterior-compartment update, hysteropexy-vs-hysterectomy meta-analyses (Ruffolo 2025; Brennand 2025), concomitant continence procedure trade-offs (CARE / OPUS / 2026 Cochrane), and a 10-row summary of core principles.
- Mesh & Graft-Augmented Prolapse RepairTransvaginal mesh and biologic-graft evidence by compartment, FDA 2019 market withdrawal, PROSPECT / FDA 522 / PROSPERE / Menefee trial anchors, mesh-specific complications, complication management, and sacrocolpopexy-vs-TVM counseling.
- Mesh Complications & RemovalCanonical reference for both POP and SUI mesh complications: 2019 FDA POP-mesh ban + carve-outs (sling, sacrocolpopexy); IUGA / ICS Category-Time-Site classification; complication-rates-by-procedure table; ACOG Committee Opinion 694 management framework; complete-vs-partial removal evidence (Bergersen POP, Doyle 2022 sling SR with partial-better-for-SUI signal, Pace 2021 outcomes-by-indication with pain-alone worst); transvaginal / abdominal / laparoscopic / robotic surgical approaches; concomitant reconstruction reality.
Decision Framework
POP management has shifted toward a patient-centered, symptom-driven approach that prioritizes native-tissue repair (NTR) as first-line for primary prolapse and reserves mesh augmentation for the situations where its durability advantage is greatest. The single most important principle across every approach is that adequate apical support must always be addressed — failure to do so is the most common cause of recurrent prolapse (ACOG PB 214). The Menefee 2024 RCT (JAMA Surg, 3-arm: NTR vs SCP vs TVM for vault prolapse) is the contemporary anchor: SCP was superior to NTR (aHR 0.57; p = 0.01) and TVM was noninferior to SCP. Hysteropexy has emerged as a viable alternative to hysterectomy with comparable / superior outcomes and reduced perioperative morbidity (Ruffolo 2025 meta n = 2,544; Brennand 2025 prospective cohort n = 321 — apical recurrence 7.5% hysteropexy vs 17.2% hysterectomy). Colpocleisis remains the most durable repair (1.8% reoperation rate; Dallas 2021) and should be considered first-line for elderly / frail patients not desiring vaginal function.
POP is a clinical diagnosis. Minimum eval: POP-Q exam (Level C), symptom assessment (bulge, pressure, urinary / bowel / sexual dysfunction), compartment determination (anterior, posterior, apical — usually multicompartment), and assessment for occult SUI with prolapse reduced (cough stress test or urodynamics) in all women with significant apical / anterior prolapse (Level C). All symptomatic patients should be offered non-surgical options first (PFMT, vaginal pessary, lifestyle modifications) before surgical reconstruction.
Treatment Selection by Clinical Scenario
| Clinical Scenario | First-Line Surgical Option | Alternative(s) | Avoid |
|---|---|---|---|
| Primary uterine prolapse, desires uterine preservation | Sacrospinous hysteropexy or Manchester procedure (vaginal); sacrohysteropexy (abdominal) | Uterosacral hysteropexy | Hysterectomy without apical support |
| Primary uterine prolapse, does not desire uterine preservation | Vaginal hysterectomy + apical suspension (USLS or SSLF) | McCall culdoplasty at hysterectomy | Hysterectomy alone (apical suspension required, Level B) |
| Post-hysterectomy vault prolapse, stage II | Vaginal NTR (USLS or SSLF) | Sacrocolpopexy (if surgeon experienced) | Mesh augmentation rarely needed at stage II (recurrence ~6% NTR vs 5% SCP) |
| Post-hysterectomy vault prolapse, stage III–IV | Sacrocolpopexy (laparoscopic / robotic) preferred | Vaginal NTR | NTR alone — USLS recurrence 25.7% vs SCP 7.8% at stage III (Lavelle 2018) |
| Anterior compartment prolapse (primary) | Anterior colporrhaphy ± apical suspension | Paravaginal repair | Isolated anterior repair without apical support |
| Posterior compartment prolapse | Posterior colporrhaphy (midline plication) | Site-specific repair | Mesh / biologic grafts in posterior repair (Level A — does NOT improve outcomes); levator plication (dyspareunia risk) |
| Recurrent anterior / apical prolapse after NTR | Sacrocolpopexy | Apical-only TVM (where permitted; experienced surgeons only) | Repeat NTR alone in stage III–IV recurrence |
| Elderly / frail, multiple comorbidities, no desire for vaginal intercourse | Colpocleisis (Le Fort or total) | — | Long reconstructive procedures in this population |
| Young / sexually active, advanced prolapse, durability prioritized | Sacrocolpopexy (with or without hysteropexy) | NTR + apical hysteropexy | Colpocleisis (precludes intercourse) |
| Concomitant occult SUI | Add anti-incontinence procedure: Burch at SCP; MUS at vaginal repair | Staged approach | Ignoring occult SUI — high de novo SUI risk after prolapse correction |
| Symptomatic, not yet failed conservative | Pessary trial + PFMT | Lifestyle modifications | Surgery before non-surgical trial |
Apical Suspension Sub-Comparison
| Feature | USLS (Vaginal) | SSLF (Vaginal) | Sacrocolpopexy | Manchester Procedure |
|---|---|---|---|---|
| Approach | Vaginal | Vaginal | Laparoscopic / robotic / open | Vaginal |
| Mechanism | Apex to uterosacral ligaments | Apex to sacrospinous ligament | Mesh from apex to sacral promontory | Cervical amputation + ligament plication |
| 2-yr success | 64.5% (OPTIMAL) | 63.1% (OPTIMAL) | ~72% / superior to NTR aHR 0.57 (Menefee 2024) | ~93% composite (Enklaar 2023 RCT — 0% reoperation at 2 yr) |
| Stage III recurrence | 25.7% (Lavelle 2018) | Comparable to USLS | 7.8% (Lavelle 2018) | Low |
| Mesh use | No | No | Yes (type 1 polypropylene) | No |
| Key risks | Ureteral kinking up to 6% — mandatory cystoscopy | Buttock / gluteal pain; hemorrhage | Mesh exposure 3–10.5% (CARE 7-yr); ileus 2.7%; VTE 0.6% | Cervical stenosis (rare); not for future pregnancy |
| OR time | Shorter | Shortest | Longest | Short |
| Best indication | Primary vault, stage II–III | Primary vault, stage II–III | Stage III–IV; recurrent; young / active | Primary uterine prolapse; completed childbearing |
Compartment Stepwise Approach
Anterior compartment
- Anterior colporrhaphy — always with concurrent apical support
- If recurrent → sacrocolpopexy or apical-only transvaginal mesh (where permitted)
Posterior compartment
- Posterior colporrhaphy (midline plication) ± perineorrhaphy
- Mesh / grafts NOT recommended (Level A — no outcome benefit)
Apical compartment
- Vaginal NTR (USLS or SSLF) — for stage II, primary prolapse
- Hysteropexy (sacrospinous, Manchester, or sacral) — if uterine preservation desired
- Sacrocolpopexy — for stage III–IV, recurrent prolapse, or when durability is prioritized
- Colpocleisis (Le Fort or total) — for elderly / frail patients not desiring vaginal function
| Procedure | Compartment | Best For |
|---|---|---|
| Pelvic Floor Muscle Training (PFMT) | All | First-line conservative therapy for symptomatic POP before surgery. |
| Prolapse Pessaries | All | Non-surgical alternative or bridge to surgery; >90% fitting success. Ring for stages II–III; Gellhorn for stage IV. |
| Lifestyle Modifications | All | Adjunct at any POP stage; obesity, constipation, and lifting modification plus the Knack. |
| Anterior Colporrhaphy | Anterior | Central cystocele from midline pubocervical fascial defect; high recurrence if isolated — pair with apical support. |
| Kelly Plication | Anterior | Historical anterior colporrhaphy + urethrovesical plication for concurrent SUI; supplanted by midurethral slings. |
| Paravaginal Repair | Anterior | Lateral cystocele (60–80% of anterior defects) — ATFP reattachment. Most often abdominal/robotic with sacrocolpopexy. |
| Michigan Four-Wall SSLF | Apical (multicompartment) | Multicompartment vaginal repair with surgeon-determined apex (DeLancey); 90% satisfaction at 8 yr (Larson 2013). |
| Posterior Colporrhaphy | Posterior | Posterior wall rectocele — midline rectovaginal fascial plication. Watch for over-correction dyspareunia. |
| Perineorrhaphy | Posterior | Perineal body laxity or distal rectocele; usually combined with posterior colporrhaphy. |
| Sacrospinous Ligament Fixation (SSLF) | Apical | Native-tissue apical suspension to the right sacrospinous ligament. |
| Uterosacral Ligament Suspension (USLS) | Apical | Bilateral apical suspension to USLs at the ischial spines. Equivalent to SSLF at 2 yr (OPTIMAL); cystoscopy mandatory. |
| McCall Culdoplasty | Apical | Native-tissue apical suspension at hysterectomy; USL plication with cul-de-sac obliteration. |
| Sacrospinous Hysteropexy | Apical | Uterus-preserving apical suspension to sacrospinous ligament. SAVE-U 1% apical failure at 5 yr. |
| Manchester-Fothergill Procedure | Apical | Uterus-preserving repair after completed childbearing with cervical elongation. |
| Iliococcygeus Fascia Suspension | Apical | Bilateral prespinous apical suspension when SSLF / USLS not feasible. Avoids the pudendal NV bundle. |
| Vaginal Hysterectomy | Apical | Symptomatic uterine prolapse, no uterine preservation desired. Concurrent apical suspension required (Level B). |
| Supracervical Hysterectomy at Sacrocolpopexy | Apical | Subtotal hysterectomy at sacrocolpopexy preserves cervix as mesh anchor. Mesh exposure 0.5% vs 4.7% total. |
| Sacrocolpopexy | Apical | Durability benchmark for apical POP; mesh from vaginal cuff to sacral promontory. |
| Sacrohysteropexy / Sacrocervicopexy | Apical | Uterine-preserving sacrocolpopexy variant; cervix to sacral promontory. |
| Laparoscopic Lateral Suspension (LLS) | Apical | Anterior-apical prolapse with uterine preservation; avoids sacral dissection. |
| Pectopexy | Apical | Mesh apical suspension to pectineal (Cooper's) ligament bilaterally; avoids presacral hemorrhage risk. |
| Transvaginal Mesh (Apical-Only Kits) | Apical | Recurrent prolapse / comorbidities; specifically trained surgeons only (ACOG Level C). Removed from US market 2019. |
| Moschcowitz Procedure | Apical | Concentric purse-string cul-de-sac obliteration for enterocele — abdominal, often with SCP / abdominal hysterectomy. |
| Halban Culdoplasty | Apical | Sagittal sutures obliterating cul-de-sac peritoneum — abdominal alternative to Moschcowitz for enterocele prevention. |
| Colpocleisis (Le Fort and Total) | All | Obliterative repair for advanced POP in elderly / frail patients not desiring intercourse. |